W. Cooper

发表

Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour

A. Ferguson-Smith, R. Grundy, E. Maher, 2005, British Journal of Cancer.

Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.

H. Neumann, E. Maher, M. Robledo, 2005, Endocrine-related cancer.

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer

E. Zabarovsky, I. Bièche, M. Broggini, 2008, Oncogene.

RASSF2 associates with and stabilizes the proapoptotic kinase MST2

L. Hesson, W. Kolch, D. Matallanas, 2009, Oncogene.

Evaluation of the 3p21.3 tumour-suppressor gene cluster

L. Hesson, F. Latif, W. Cooper, 2007, Oncogene.

Silencing of CDKN1C ( p57 KIP2 ) is associated with hypomethylation at KvDMR1 in Beckwith–Wiedemann syndrome

C. Junien, W. Reik, N. Diaz-Meyer, 2003 .

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours

I. Bièche, E. Maher, F. Latif, 2008, Breast Cancer Research.

Beckwith-Wiedemann syndrome and assisted reproduction technology (ART)

W. Reik, S. Bowdin, J. Sampson, 2003, Journal of medical genetics.

Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome

Richard C Trembath, Paul Gissen, Colin A. Johnson, 2004, Nature Genetics.

Beckwith-Wiedemann syndrome and assisted reproduction technology (ART)

W. Reik, S. Bowdin, J. Sampson, 2003, Journal of medical genetics.

The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-κB signaling pathways

Thomas L. Dunwell, E. Zabarovsky, W. Kolch, 2010, Oncogene.